Anis Baidura Azal holds a Masters scholarship funded by the Government of Malaysia;Norshamsiah Md Din receives funding from the UKMMC Fundamental Research Fund(No.FF-2019-058)。
AIM:To evaluate whether latanoprost/timolol fixed combination(LTFC)dosed twice daily may provide further intraocular pressure(IOP)reduction and evaluate the safety profile at this dose.METHODS:This is an open-labeled,...
financially supported by the Liao Ning Revitalization Talents Program(XLYC1902061)。
Currently commercial fixed-concomitant three agents have multiple problems such as multiple dosing administration,poor efficacy and side effects.Once-daily fixed-combination timolol-netarsudil-latanoprost ophthalmic s...
AIM: To evaluate the therapeutic efficacy, safety and tolerability of newly developed preservative-free(PF) latanoprost generic [TJO-002] and compare it with benzalkonium chloride(BAK)-preserved latanoprost [Xalatan?]...
Shanghai No.6 Hospital Group(No.18-LY-03);Putuo Hospital Shanghai University of Traditional Chinese Medicine(No.2017301A)。
AIM:To investigate the effect of latanoprost eye drops on the conjunctival lymphatics.METHODS:Twenty-four healthy New Zealand White rabbits weighing 1.5 to 2.0 kg were randomly divided into three groups:latanoprost gr...
Supported by Program of Scientific and Technological Plan of Xi’an[No.2017116SF/YX010(10)];Program of Key Research and Invention Plan of Shaanxi(No.2017SF-266).
AIM:To evaluate the intraocular pressure(IOP)-lowering efficacy and safety of tafluprost 0.0015%eye drops[benzalkonium chloride(BAK)0.1 mg/mL]compared with that of latanoprost 0.005%eye drops(BAK 0.2 mg/mL)for primary...
Supported by a grant from Putuo Hospital affiliated to Shanghai University of Traditional Chinese Medicine(No.2071301A);a fund program from Shanghai University of Traditional Chinese Medicine for incubation of doctor degree(No.B 201708/J-16-11)
AIM: To investigate the effect of long-term use of topically administered latanoprost on conjunctival thickness(CT) and conjunctival epithelium thickness(CET) in the patients with glaucoma. METHODS: A series of...
AIM: To establish the efficacy and safety of bimatoprost 0.03% monotherapy in glaucoma and ocular hypertension (OHT) patients with inadequate intraocular pressure (lOP) on current therapy. METHODS: Pre- and pos...
Supported by the National Natural Science Foundation of China(No.81400428);Science and Technology Commission of Shanghai Municipality(No.134119b1600)
AIM: To investigate the intraocular pressure(IOP) of adult guinea pig eyes with rebound tonometry(RBT),and assess the effects of four distinctive topical IOP reducing medications including Carteolol,Brimonidine,B...
supported by the 2013–2014 Bristol-Myers Squibb Virology Fellows Research Training Program.The manuscript received no direct financial support.
Ulcerative colitis and Crohn’s disease(CD)are characterized by inflammation of the intestinal mucosa and symptoms of abdominal pain and diarrhea.Many studies have shown an association between elevated levels of prost...
AIM:To assess the effects of the fixed combination of0.005% latanoprost and 0.5% timolol(FCLT) vs their individual components for primary open angle glaucoma(POAG) and ocular hypertension(OHT).· METHODS:After searche...